Office of The Director, National Institutes of Health; Notice of Meetings, 62662 [07-5534]
Download as PDF
62662
Federal Register / Vol. 72, No. 214 / Tuesday, November 6, 2007 / Notices
Dated: October 29, 2007.
Raynard S. Kington,
Deputy Director, NIH.
[FR Doc. E7–21799 Filed 11–5–07; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of The Director, National
Institutes of Health; Notice of Meetings
mstockstill on PROD1PC66 with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following meeting
of the Advisory Committee to the
Director, NIH.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Advisory Committee
to the Director, NIH.
Date: December 7, 2007.
Time: 8:30 a.m. to 5 p.m.
Agenda: Among the topics proposed for
discussion are: (1) NIH Director’s Report; (2)
NIH Director’s Council of Public
Representatives Liaison Report; and (3) ACD
Peer Review Work Group Report.
Place: National Institutes of Health,
Building 31, Conference Room 6, 9000
Rockville Pike, Bethesda, MD 20892.
Contact Person: Penny W. Burgoon, PhD,
Senior Assistant to the Deputy Director,
Office of the Director, National Institutes of
Health, 1 Center Drive, Building 1, Room
114, Bethesda, MD 20892, 301–451–5870,
burgoonp@od.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.nih.gov/about/director/acd.htm, where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
VerDate Aug<31>2005
16:55 Nov 05, 2007
Jkt 214001
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrom Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: October 30, 2007
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–5534 Filed 11–5–07; 8:45am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Career Transition Award (K22).
Date: November 27, 2007.
Time: 1:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Tony L. Creazzo, PhD,
Scientific Review Administrator, Review
Branch/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7180, Bethesda, MD 20892–7924, 301–435–
0725, creazzot@mail.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Institutional National Research Service
Awards (T32s).
Date: November 28, 2007.
Time: 10 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Roy L. White, PhD,
Scientific Review Administrator, Review
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Branch/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7176, Bethesda, MD 20892–7924, 301–435–
0310, whiterl@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Conference Grants (R13s).
Date: November 28, 2007.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Chang Sook Kim, PhD,
Scientific Review Administrator, Review
Branch, DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7190, Bethesda, MD 20892, 301–435–0287,
carolko@mail.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Patient-Oriented and Career Enhancement
Award for Stem Cell Research (K 23, 24, 25).
Date: November 29–30, 2007.
Time: 8 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crystal City Marriott, 2899 Jefferson
Davis Highway, Arlington, VA 22202.
Contact Person: Mark Roltsch, PhD,
Scientific Review Administrator, Review
Branch/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7192, Bethesda, MD 20892–7924, 301–435–
0287, roltschm@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Ancillary Studies in Clinical Trials.
Date: November 30, 2007.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Yingying Li-Smerin, MD,
PhD, Scientific Review Administrator,
Review Branch/DERA, National Heart, Lung,
and Blood Institute, 6701 Rockledge Drive,
Room 7184, Bethesda, MD 20892–7924, 301–
435–0277, lismerin@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: October 29, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–5516 Filed 11–5–07; 8:45 am]
BILLING CODE 4140–01–M
E:\FR\FM\06NON1.SGM
06NON1
Agencies
[Federal Register Volume 72, Number 214 (Tuesday, November 6, 2007)]
[Notices]
[Page 62662]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-5534]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of The Director, National Institutes of Health; Notice of
Meetings
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting of the Advisory Committee to the Director, NIH.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Advisory Committee to the Director, NIH.
Date: December 7, 2007.
Time: 8:30 a.m. to 5 p.m.
Agenda: Among the topics proposed for discussion are: (1) NIH
Director's Report; (2) NIH Director's Council of Public
Representatives Liaison Report; and (3) ACD Peer Review Work Group
Report.
Place: National Institutes of Health, Building 31, Conference
Room 6, 9000 Rockville Pike, Bethesda, MD 20892.
Contact Person: Penny W. Burgoon, PhD, Senior Assistant to the
Deputy Director, Office of the Director, National Institutes of
Health, 1 Center Drive, Building 1, Room 114, Bethesda, MD 20892,
301-451-5870, burgoonp@od.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: https://www.nih.gov/about/director/acd.htm, where an agenda and
any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrom Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: October 30, 2007
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-5534 Filed 11-5-07; 8:45am]
BILLING CODE 4140-01-M